All data are based on the daily closing price as of October 30, 2025
c

Chong Kun Dang Pharmaceutical

185750.KO
57.65 USD
-0.27
-0.47%

Overview

Last close
57.65 usd
Market cap
759.66M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
79.06 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.6525
Price/Book Value
1.1884
Enterprise Value
751.12M usd
EV/Revenue
0.6444
EV/EBITDA
9.1641

Key financials

Revenue TTM
1.17B usd
Gross Profit TTM
363.69M usd
EBITDA TTM
78.42M usd
Earnings per Share
N/A usd
Dividend
0.77 usd
Total assets
1.11B usd
Net debt
44.41M usd

About

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top